Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00088049
First received: July 19, 2004
Last updated: July 16, 2007
Last verified: July 2007